Citron Research Updates Emcore (EMKR)
Up)
Today, Citron Research updated its opinion of Emcore (Nasdaq: EMKR). Citron is a widely followed short seller who has written negative pieces on Arthrocare (Nasdaq: ARTC), Home Solutions (OTCBB: HSOA) and others in the past. Ostensibly, his next target is Emcore.
Citron said Emcore is reminiscent of Home Solutions. Home Solutions now trades for under a $1. Citron believes that Emcore needs to become profitable to fix its problems.
Also, Citron said, if Emcore's Green and Gold Energy is revealed to be an 'empty shell,' Citron said Emcore would in turn miss its earnings. [JT]
Citron Research
Sign up at EasyStockAlerts.com & Make Money Today!
The Disciplined Investor - Essential Strategies for Success
Citron said Emcore is reminiscent of Home Solutions. Home Solutions now trades for under a $1. Citron believes that Emcore needs to become profitable to fix its problems.
Also, Citron said, if Emcore's Green and Gold Energy is revealed to be an 'empty shell,' Citron said Emcore would in turn miss its earnings. [JT]
Citron Research
Sign up at EasyStockAlerts.com & Make Money Today!
The Disciplined Investor - Essential Strategies for Success
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Facebook (FB) Short Interest Nears Double-Digit Levels
- EMC (EMC): Still Underestimated Despite All the Potential - Barron's
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
